- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x 65L: [1-[3-fluoranyl-4-[(2-piperidin-4-yloxy-1,6-naphthyridin-7-yl)amino]phenyl]pyrazol-3-yl]methanol(Non-covalent)
- 10 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 4 residues within 4Å:- Chain A: I.10, D.86, Q.130
- Ligands: 65L.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.86, A:D.86
EDO.3: 3 residues within 4Å:- Chain A: H.60, K.61, R.65
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.65
EDO.4: 4 residues within 4Å:- Chain A: V.272, Q.273, R.274, E.279
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.274
EDO.5: 4 residues within 4Å:- Chain A: K.104, S.105, F.108, F.286
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.286
- Water bridges: A:S.105, A:S.105
EDO.6: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.7: 6 residues within 4Å:- Chain A: Q.85, Y.90, I.134, N.135, R.136, G.138
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.85, A:R.136
EDO.8: 3 residues within 4Å:- Chain A: E.57
- Chain B: S.171
- Ligands: PEG.9
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.171
- Water bridges: B:S.172
EDO.18: 4 residues within 4Å:- Chain B: S.172, L.175, Q.176, A.179
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.172, B:Q.176
EDO.19: 4 residues within 4Å:- Chain B: E.117, V.118, G.119, E.123
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.119
EDO.20: 3 residues within 4Å:- Chain B: S.51, E.52, R.55
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.52, B:E.52
- Water bridges: B:R.55
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.9: 6 residues within 4Å:- Chain A: K.56, K.59, L.66, H.67, D.68
- Ligands: EDO.8
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.56, A:K.56, A:K.59
PEG.10: 7 residues within 4Å:- Chain A: S.247, L.248, V.249, A.257, R.260, D.261, Q.264
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:S.247, A:L.248, A:V.249, A:A.257, A:R.260
- Water bridges: A:D.261
- 7 x CL: CHLORIDE ION(Non-functional Binders)
CL.11: 2 residues within 4Å:- Chain A: K.213, K.237
Ligand excluded by PLIPCL.12: 6 residues within 4Å:- Chain A: E.51, V.64, F.80, A.143, D.144
- Ligands: 65L.1
Ligand excluded by PLIPCL.13: 3 residues within 4Å:- Chain A: Y.4, N.23, V.30
Ligand excluded by PLIPCL.14: 2 residues within 4Å:- Chain A: K.268, C.269
Ligand excluded by PLIPCL.15: 2 residues within 4Å:- Chain A: Y.236, Y.239
Ligand excluded by PLIPCL.16: 1 residues within 4Å:- Chain A: G.138
Ligand excluded by PLIPCL.21: 2 residues within 4Å:- Chain B: R.67, K.69
Ligand excluded by PLIP- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Daniels, M.H. et al., Discovery and Optimization of Highly Selective Inhibitors of CDK5. J.Med.Chem. (2022)
- Release Date
- 2022-03-09
- Peptides
- Cyclin-dependent-like kinase 5: A
Cyclin-dependent kinase 5 activator 1, p25: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x 65L: [1-[3-fluoranyl-4-[(2-piperidin-4-yloxy-1,6-naphthyridin-7-yl)amino]phenyl]pyrazol-3-yl]methanol(Non-covalent)
- 10 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 7 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Daniels, M.H. et al., Discovery and Optimization of Highly Selective Inhibitors of CDK5. J.Med.Chem. (2022)
- Release Date
- 2022-03-09
- Peptides
- Cyclin-dependent-like kinase 5: A
Cyclin-dependent kinase 5 activator 1, p25: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
C